FindTrial
Sign In

Application of rapid frozen section examination in mpMRI/TRUS fusion prostate biopsy

Application of rapid frozen section examination in mpMRI/TRUS fusion prostate biopsy

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
ChiCTR
Registry ID
ChiCTR2000040789
Enrollment
Unknown
Registered
2020-12-10
Start date
2020-02-01
Completion date
Unknown
Last updated
2021-04-12

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

prostate cancer

Interventions

Gold Standard:Routine pathological examination
Index test:Quick&#32
frozen&#32
section&#32
examination

Sponsors

Northern Jiangsu People’s Hospital
Lead Sponsor

Eligibility

Sex/Gender
Male
Age
51 Years to 82 Years

Inclusion criteria

Inclusion criteria: (1) Rectal digital examination showed nodules; (2) Prostate-specific antigen (PSA) 4-10 ng/mL, abnormal free/total PSA or PSA density; (3) PSA>10 ng/ml or total PSA 4~10 ng/ml, F/T<0.16); (4) No treatment or puncture biopsy was performed before MRI examination.

Exclusion criteria

Exclusion criteria: (1) Contraindication of MRI examination; (2) Poor image quality or incomplete image, so it cannot be analyzed; (3) NO suspicious area in mpMRI; (4) Previous history of prostate needle biopsy or treatment (radiotherapy, chemotherapy or surgery).

Design outcomes

Primary

MeasureTime frame
positive rates;Single needle positive rate;—

Countries

China

Contacts

Public ContactDing Xue-fei

Northern Jiangsu people’s Hospital

xuefeid@126.com+86 18051061234

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 13, 2026